x

Drug Discovery Solutions

Current drug development strategies can be costly and too often experience high attrition rates in later stages of Drug Development. Predictive preclinical models and assays for efficacy and safety testing could help address these challenges. Ncardia combines Cardiovascular and Neural cell expertise with commercial iPSC manufacturing experience to provide predictive and translational assays at any throughput.

See our Drug Discovery assay catalogue

What we do best

Ncardia helps solve your technical challenges

 

 

Comprehensive iPSC-based Drug Discovery platform

 

 

Solutions developed based on your requirements

 

 

15 years implementing stem cell technologies

 

 

Human iPSC knowledge, IP and infrastructure

Cell models

Translating an in vitro cellular model into clinically relevant insights from assay read-outs first requires a functional and validated model.

Our human iPSC-derived cardiomyocytes and neural cells are produced and tested within a stringent Quality Manufacturing System.

Explore a selection of available cell models

Drug Discovery Assays

Successful drug discovery studies require robust efficacy and safety assays to establish compound effects throughout the drug discovery funnel.

Ncardia applies human iPSC technologies within a menu of qualified assays to support your drug discovery activities.

See the catalog of Drug Discovery assays

DiscoverHIT Screening Platform

DiscoverHIT is a full service HTS-screening platform based on human induced pluripotent stem cell technology

Efficacy of compound libraries are assayed and screened on your specific disease model. This comprehensive service is comprised of four integrated modules; disease modeling, manufacturing, assay development and high throughput phenotypic screening.

Discover more

Safety Services

Ncardia develops and delivers state of the art integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates.

Our services are based on fully functional and validated hiPSC-derived cardiomyocytes that are manufactured under strict quality assurance.

Our safety services

Project process

1. Initial inquiry

Initial inquiry through the website, email or business development representative.

2. Consultation

Consultation with our cross-functional Ncardia team to discuss your request, understand your needs and set expectations correctly.

3. Expert team

Assignment of Lead Scientist, Project Manager and expert team to manage your custom request.

4. Project plan

For custom projects we will draft a detailed project plan including clear timelines and milestones.

5. Finetuning

The project plan is reviewed by you and finalized including your final input and a payment structure.

6. Execution

Execution of the project with regular interaction with you.

7. Delivery

A final report will be created and presented. At this stage there should be no surprises.

8. Feedback

We would love to hear your feedback and discuss your next project.